Outcome of Board Meeting_Monitoring Agency Report

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+2.6%1-day move

₹382.30

prior close

₹379.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+4.4+3.6+3.7+2.7+2.6+5.6+8.9+9.4+12.6+12.4+11.7+6.7+4.0—

Up moveDown movePending

AI summary

Biocon Limited has submitted its quarterly Monitoring Agency Report for Q4 FY2026 (ending March 31, 2026). The report, issued by India Ratings & Research Private Limited, covers the utilisation of proceeds raised through a Qualified Institutions Placement (QIP). Both the Audit Committee and Board of Directors reviewed and noted the report at their meetings held on May 7, 2026. This filing complies with SEBI regulations 32(6) of LODR and 173A of ICDR, which mandate periodic monitoring of QIP fund usage. The actual utilisation details are contained in the attached report rather than the covering letter itself.

Likely market impact

This is a routine compliance filing confirming proper oversight of QIP proceeds. No immediate impact on stock price expected, though it assures investors that funds raised are being monitored as required by SEBI.